Curi Bio’s ribbon cutting in April 2025 for its new headquarters on Seattle’s waterfront. Elliot Fisher, co-founder and chief business officer, cuts the ribbon with a sword while CEO Nicholas Geisse ...

Tune Therapeutics’ co-founders, from left: Akira Matsuno, chief financial officer; Charles Gersbach; and Fyodor Urnov, who also serves on the startup’s scientific advisory board. (Tune Photos) Tune ...

Marta Fields knew disease, as an expert in how drugs get approved. Fields, 74, spent 35 years navigating the regulatory maze meant to ensure that any medicines that hit the market are safe and ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company will use the money ...

Seattle biotech startup Curi Bio, which enables the screening of new drugs using cells and 3D tissue models derived from human cells, announced $10 million in new funding. Curi Bio’s customers include ...

Tune Therapeutics, a biotech company with headquarters in Seattle and Durham, N.C., raised $175 million in one of the largest funding rounds for a Seattle-area startup in recent years. Tune is using a ...